Institutional investors purchased a net $4.5 million shares of IMMU during the quarter ended December 2012, and now own 39.86% of the total float, a percentage that is typical for companies in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
FIDELITY MANAGEMENT & RESEARCH C... Bought 1.3 Million shares of Immunomedics Inc
RA CAPITAL MANAGEMENT LLC Bought 1.0 Million shares of Immunomedics Inc
PINE RIVER CAPITAL MANAGEMENT LP Bought 875.0 Thousand shares of Immunomedics Inc